HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Construction and evaluation of red blood cells-based drug delivery system for chemo-photothermal therapy.

Abstract
In this study, a novel tumor-targeting drug delivery system (DDS) based on red blood cells (RBCs) were fabricated for combinational chemo-phototherapy against cancer. Cyclic peptide (cRGD) and indocyanine green (ICG) were applied to the surface of RBCs to increase the targeting and photothermal effect, respectively. Doxorubicin (DOX) as a model drug was loaded into RBCs by the hypotonic dialysis method. A series of tests have been carried out to evaluate the RBCs-based DDS and these tasks include physicochemical properties, cellular uptake, targeting ability, and combination therapeutic efficiency. As a result, the DOX was successfully loaded into RBCs and the drug loading amount was 0.84 ± 0.09 mg/mL. There was no significant change of particle size after surface modification of RBCs. The RBCs-based DDS could target to the surface of cancer cells, which delivery DOX to the lesions efficiently and accurately. Meanwhile, due to the combined treatment effect, the RBCs-based DDS can effectively inhibit tumor growth. The RBCs-based DDS constructed in this research may have promising applications in cancer therapy due to their highly synergistic efficient therapy and to investigate its possibility for tumor therapy.
AuthorsChen Wang, Jingru Huang, Yan Zhang, Hongxin Jia, Binbin Chen
JournalColloids and surfaces. B, Biointerfaces (Colloids Surf B Biointerfaces) Vol. 204 Pg. 111789 (Aug 2021) ISSN: 1873-4367 [Electronic] Netherlands
PMID33932889 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier B.V. All rights reserved.
Chemical References
  • Pharmaceutical Preparations
  • Doxorubicin
Topics
  • Cell Line, Tumor
  • Doxorubicin (pharmacology)
  • Drug Delivery Systems
  • Drug Liberation
  • Erythrocytes
  • Hyperthermia, Induced
  • Nanoparticles
  • Pharmaceutical Preparations
  • Phototherapy
  • Photothermal Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: